Biopharmaceuticals

Over the next 10 years, health care costs are predicted to double, raising the pressure for the industry worldwide.

Biopharmaceutical companies have the opportunity to lead the way by creating health care strategies and solutions that are both feasible and affordable. Above all else, this means working with providers on improving health outcomes—not just selling medicines.

• Adopt new business models: As biologics play an increasingly important role in the development of new products, top firms are getting up to speed on an entirely different business model that involves new skills, processes, and competitors.
•  Increase focus on mergers and partnerships: To reduce risk, biopharmaceutical companies are restructuring their businesses through M&A, partnerships, outsourcing, and, in some instances, vertical integration.
• Raise quality standards: In a stricter regulatory environment with far greater penalties for safety violations, companies are proactively taking steps to improve the quality of their offerings.

PRTM's biopharmaceutical consulting teams work with companies in these strategic areas, helping them optimally structure their businesses, revamp processes to comply with stricter regulations, boldly enter new lines, get products to market faster, and scale up operations for commercialization.